Benign Conditions

AUA 2020: Disorders of ejaculation guidelines hailed as “most scientifically rigorous to date”

June 30, 2020

Alan W. Shindel, MD, provides an expert summary and analysis of the 2020 AUA Guidelines for Disorders of Ejaculation.

Rechargeable neuromodulation system safe and efficacious through 1 year

June 30, 2020

The reduction in urinary urgency incontinence episodes observed was “quite significant,” an investigator said.

Sulopenem hits key end point in phase 3 uncomplicated UTI trial

June 29, 2020

The novel oral penem anti-infective compound sulopenem showed stronger clinical activity than ciprofloxacin in patients with uncomplicated urinary tract infections with quinolone resistant pathogens, according to findings from the phase 3 SURE1 trial.

Dr. Weiss on defining nocturia and separating it from overactive bladder

June 26, 2020

In this interview, Gopal H. Badlani speaks to Jeffrey P. Weiss, MD, regarding how Weiss defines nocturia and separating the symptom from overactive bladder.

AUA updates guideline for surgical management of BPH-related lower urinary tract symptoms

June 25, 2020

The guidelines are an evidence-based clinical reference for the treatment of patients with lower urinary tract symptoms secondary to BPH.

Photoselective vaporization of the prostate found safe, durably effective

June 23, 2020

Only 1.5% of patients undergo repeat surgical intervention for BPH recurrence.

PROs favor prostatic urethral lift over water vapor ablation for BPH symptoms

June 22, 2020

Patient-reported outcomes showed a superior experience regarding post-procedure BPH symptoms with the UroLift prostatic urethral lift over Rezum tissue ablation with steam injection.

Minimally invasive treatments grab BPH spotlight

January 30, 2019

Minimally invasive surgical options took front and center in 2018 when the AUA published its revised guideline on the surgical management of male lower urinary tract symptoms secondary to BPH.

TURP duration linked with complication rate

November 20, 2018

Procedure safest when performed in

OAB patients continue medical therapy unnecessarily

November 20, 2018

A recent study found that sacral neuromodulation monotherapy was efficacious as a third-line treatment.